The big picture about Lumosity, Posit Science and Emotiv

How can inno­va­tors lever­age crowd­fund­ing and strate­gic invest­ments to gain dis­tri­b­u­tion reach? from SharpBrains: Tracking Brain Health Innovation You can now enjoy the slide deck from this session, which took place at the 2013 SharpBrains Virtual Summit (September 19-20th). How can inno­va­tors lever­age crowd­fund­ing and strate­gic invest­ments to gain dis­tri­b­u­tion reach?  With dis­tri­b­u­tion as a com­mon bot­tle­neck to the sus­tain­able com­mer­cial­iza­tion of inno­va­tion, value-added cap­i­tal is often crit­i­cal to enable steady progress in the trans­la­tion of brain sci­ence from lab to life. This is espe­cially true in non-medical areas, which lack appro­pri­ate infra­struc­ture to com­mer­cial­ize and dis­trib­ute inno­v­a­tive solu­tions. What can inno­va­tors learn from Discovery’s invest­ment in Lumos­ity, AAA’s part­ner­ship with Posit Sci­ence, and Emotiv’s Kick­starter crowd­fund­ing campaign? Chair: Matthew Bishop, US Busi­ness Edi­tor and New York Bureau Chief of The Econ­o­mist Dan Fox, Senior VP Cor­po­rate Devel­op­ment at Dis­cov­ery Communications Jeff Zim­man, Chair­man of Posit Science Tan Le, CEO of Emo­tiv Life­sciences
Source: SharpBrains - Category: Neurologists Authors: Tags: Cognitive Neuroscience Technology brain-science crowd funding Dan Fox discovery communication emotive Jeff Zimman Lumosity mathew bishop Posit-Science Source Type: blogs